Managed Syndicates – The “Why” for Investors
why
Managed Syndicates for investors
by Michael Schmanske

Okay so we’ve covered “What are Managed Syndicates?” How about “WHY are Managed Syndicates?”

For Investors in early stage startups you have a choice. Go alone or with a group. If you are a High Net Worth individual and have the liquidity to invest and manage investments with $250,000 lump sum minimums, you might choose to go it alone. (I’ll discuss shortly why you may still want to invest with a group.)

But the vast majority of successful professionals investing in private equity would (should) rather invest in a portfolio of companies rather than placing all their eggs in one basket. For most of us, we should pool our resources as a syndicate and utilize SPV’s to meet investment minimums.

“Skinny” Syndicates redux

If you have not already, I recommend reading, or at least skimming, the three prior posts in this series.

So Skinny syndicates – those without management wrappers. Generally charge lower fees, but provide no investor (or company) support. The investment vehicle does not include a management team which leads to “fire and forget” behavior. Once created, the management company has no budget to support investment follow-up or company support. Investors still want a full management experience, but this isn’t reality.

Many investors have invested in Skinny syndicates for real estate or other revenue generating assets. If you read the fine print you’ll find the GP, the management company or advisory team is being well compensated via the revenue stream (Rents, royalties, etc) before earnings are distributed to investors. So while the top line fee seems low, the embedded cost framework is actually quite high. (By the way – Mutual funds and others do the same. Transaction costs and some other expenses like research are paid by the investment portfolio not by the management team.)

You get what you pay for.

AngelMD Capital LLC launched a Managed Syndicate product this Summer.

Wait for it…

We charge fees. It is the right thing to do. By creating a structure with an Administrative and Portfolio Manager fee wrap, the vehicle assumes greater responsibility for Investor relations, company updates and direct portfolio support via the AngelMD network. Let’s unpack that…

Fees: AngelMD Capital collects fees to support important service improvements: 10% in total and 15% carry. That’s it. Full stop. The 10% is for the life of the investment and is distributed as 2%/yr for the first three years and 0.40%/yr for ten years. When an exit is achieved, non-distributed fees are returned to the investors (The LP’s). These fees are slightly higher than “Skinny” Syndicates but lower than most, if not all managed funds.

Investor Relations: Informational updates to LP’s including annual reports, quarterly updates and timely tax documents. Anyone that has invested via a startup syndicate is likely familiar with the frustration or confusion of what’s going on due to lack of communication with company management. Startups are scrambling and rarely get updates to investors and even more rare to get them out on a regular basis. Tax time? Fahgettaboudit.

At AngelMD Capital, tax season is a misery. Our team gets the unenviable and unrewarded job of cajoling the host of startups with past syndications to provide annual reporting documents to the syndicate administrator so they may provide relevant tax filing paperwork to the investors. It’s incredibly inefficient.

An administrative fee allows us to budget an Investor Relations representative. No longer will LP’s feel in the dark about how their investment is doing as they receive periodic updates on valuation or progress towards an investment exit.

Active Startup support and communications between the startup and the AngelMD expert Network: While the items above are valuable, they really represent a feel-good value. The real value comes in the form of active support of the portfolio. Every Managed syndicate includes a requirement that a representative of the AngelMD Clinical Advisory Board join the company board meetings and maintain a continuous line of communication with company management. The cool part of this is that doctors often want to join these startups. It satisfies monetary, intellectual and career goals. For their part, the companies would normally have to pay a headhunter to find interested experts in their specialty. We work with company management to find a Key Opinion Leaders in our network that they will find valuable as ongoing advisors.

By supporting a PM team and board seat, the company will have ongoing senior level connectivity to the valuable AngelMD expert Network. If a company requires advice, connections, trial or distribution support, or help with any other issue that comes up, they have a BatPhone that dials directly to the Clinicians in our network. This is a big benefit to startups. But in the end it is also a boon to the investors themselves. It is also why larger investors are leaning in to our structure. Even a large Asset Manager or Family Office can unlock significant value investing side by side with our network.

I like to (over) use metaphors. I often call our doctors and our advisors the “Sherpas” for companies, as they climb the entrepreneurial mountain. I also like to compare our Syndicates to Conestoga Wagon Trains. Join the train with the most experienced fellow travelers and the most capable guides. It is the best way to forge ahead through unknown landscapes and reach the Land of Plenty.

To learn more about Managed Syndicates and guarantee you hear about all of our deals as they become available fill out THIS FORM.
Facebook
Twitter
LinkedIn

Recent Posts

Lessons Learned – Medical Device

What Not To Do We can learn from our wins, but it’s often the things…

JP Morgan Week 2023

For most startups and investors in the healthcare industry, the week of JP Morgan’s Healthcare…

Raising Early Stage Capital

While we have covered aspects of this topic in almost 100 blog articles over the…